Choose the VFD control mode based on the ratio of the system pressure to maximum internal pump pressure. For a centrifugal pump delivering to a system with high operating pressure and or high static ...
Following Priority Review, the U.S. FDA granted HYRNUO® (sevabertinib) approval for the treatment of adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) ...
Abstract: Various static code analysis tools have been designed to automatically detect software faults and security vulnerabilities. This paper aims to 1) conduct an empirical evaluation to assess ...
During a live event, Nataliya Mar, MD, discussed systemic therapies such as lenvatinib/pembrolizumab in advanced renal cell carcinoma based on recent trials. Renal cell carcinoma (RCC) treatment has ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved Hernexeos for adults with unresectable or metastatic HER2-mutant NSCLC. It received accelerated ...
Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes. HealthDay News — Men with nonmetastatic prostate cancer receiving ...
XTANDI: the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in non-metastatic hormone-sensitive prostate cancer (nmHSPC) with high-risk biochemical ...
When non-small cell lung cancer (NSCLC) spreads beyond the lungs, it often metastasizes to the bones. Estimates suggest 20 to 30 percent of people with NSCLC have bone metastases at the time of ...
Findings showed in the ITT population, zanzalintinib plus atezolizumab statistically significantly reduced the risk of death compared with regorafenib. Topline data were announced from a phase 3 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results